|
1.
|
Siegel R, DeSantis C, Virgo K, et al:
Cancer treatment and survivorship statistics, 2012. CA Cancer J
Clin. 62:220–241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Herbst RS, Heymach JV and Lippman SM: Lung
cancer. N Engl J Med. 359:1367–1380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
O’Byrne KJ, Gatzemeier U, Bondarenko I, et
al: Molecular biomarkers in non-small-cell lung cancer: a
retrospective analysis of data from the phase 3 FLEX study. Lancet
Oncol. 12:795–805. 2011.PubMed/NCBI
|
|
4.
|
Pietanza MC and Rudin CM: Novel
therapeutic approaches for small cell lung cancer: the future has
arrived. Curr Probl Cancer. 36:156–173. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Travis WD: Advances in neuroendocrine lung
tumors. Ann Oncol. 21(Suppl 7): vii65–vii71. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Swarts DR, Ramaekers FC and Speel EJ:
Molecular and cellular biology of neuroendocrine lung tumors:
evidence for separate biological entities. Biochim Biophys Acta.
1826:255–271. 2012.PubMed/NCBI
|
|
7.
|
Levine B and Kroemer G: Autophagy in the
pathogenesis of disease. Cell. 132:27–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Mathew R and White E: Autophagy in
tumorigenesis and energy metabolism: friend by day, foe by night.
Curr Opin Genet Dev. 21:113–119. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Mizushima N and Komatsu M: Autophagy:
renovation of cells and tissues. Cell. 147:728–741. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Klionsky DJ, Codogno P, Cuervo AM, et al:
A comprehensive glossary of autophagy-related molecules and
processes. Autophagy. 6:438–448. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Tanida I, Ueno T and Kominami E: LC3 and
autophagy. Methods Mol Biol. 445:77–88. 2008. View Article : Google Scholar
|
|
12.
|
Chen ZH, Kim HP, Sciurba FC, et al: Egr-1
regulates autophagy in cigarette smoke-induced chronic obstructive
pulmonary disease. PLoS One. 3:e33162008. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Lahm T and Petrache I: LC3 as a potential
therapeutic target in hypoxia-induced pulmonary hypertension.
Autophagy. 8:1146–1147. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Righi L, Volante M, Rapa I, Scagliotti GV
and Papotti M: Neuroendocrine tumours of the lung. A review of
relevant pathological and molecular data. Virchows Arch. 451(Suppl
1): S51–S59. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Taneja TK and Sharma S: Markers of small
cell lung cancer. World J Surg Oncol. 2:102004. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Lum JJ, DeBerardinis RJ and Thompson CB:
Autophagy in metazoans: cell survival in the land of plenty. Nat
Rev Mol Cell Biol. 6:439–448. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Maiuri MC, Tasdemir E, Criollo A, et al:
Control of autophagy by oncogenes and tumor suppressor genes. Cell
Death Differ. 16:87–93. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Sarbassov DD, Guertin DA, Ali SM and
Sabatini DM: Phosphorylation and regulation of Akt/PKB by the
rictor-mTOR complex. Science. 307:1098–1101. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Mostoslavsky G, Fabian AJ, Rooney S, Alt
FW and Mulligan RC: Complete correction of murine Artemis
immunodeficiency by lentiviral vector-mediated gene transfer. Proc
Natl Acad Sci USA. 103:16406–16411. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Rubinson DA, Dillon CP, Kwiatkowski AV, et
al: A lentivirus-based system to functionally silence genes in
primary mammalian cells, stem cells and transgenic mice by RNA
interference. Nat Genet. 33:401–406. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Vindelov LL, Christensen IJ and Nissen NI:
A detergent-trypsin method for the preparation of nuclei for flow
cytometric DNA analysis. Cytometry. 3:323–327. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Hong SK, Yoon S, Moelling C, Arthan D and
Park JI: Noncatalytic function of ERK1/2 can promote
Raf/MEK/ERK-mediated growth arrest signaling. J Biol Chem.
284:33006–33018. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Phelps RM, Johnson BE, Ihde DC, et al:
NCI-Navy Medical Oncology Branch cell line data base. J Cell
Biochem. (Suppl 24): 32–91. 1996. View Article : Google Scholar
|
|
24.
|
Hers I, Vincent EE and Tavare JM: Akt
signalling in health and disease. Cell Signal. 23:1515–1527. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Dazert E and Hall MN: mTOR signaling in
disease. Curr Opin Cell Biol. 23:744–755. 2011. View Article : Google Scholar
|
|
26.
|
Thoreen CC, Kang SA, Chang JW, et al: An
ATP-competitive mammalian target of rapamycin inhibitor reveals
rapamycin-resistant functions of mTORC1. J Biol Chem.
284:8023–8032. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Laplante M and Sabatini DM: mTOR signaling
in growth control and disease. Cell. 149:274–293. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Potter CJ, Pedraza LG and Xu T: Akt
regulates growth by directly phosphorylating Tsc2. Nat Cell Biol.
4:658–665. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Vander Haar E, Lee SI, Bandhakavi S,
Griffin TJ and Kim DH: Insulin signalling to mTOR mediated by the
Akt/PKB substrate PRAS40. Nat Cell Biol. 9:316–323. 2007.PubMed/NCBI
|
|
30.
|
Ryter SW and Choi AM: Autophagy in the
lung. Proc Am Thorac Soc. 7:13–21. 2010. View Article : Google Scholar
|
|
31.
|
Eckardt JR, von Pawel J, Pujol JL, et al:
Phase III study of oral compared with intravenous topotecan as
second-line therapy in small-cell lung cancer. J Clin Oncol.
25:2086–2092. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
O’Brien ME, Ciuleanu TE, Tsekov H, et al:
Phase III trial comparing supportive care alone with supportive
care with oral topotecan in patients with relapsed small-cell lung
cancer. J Clin Oncol. 24:5441–5447. 2006.PubMed/NCBI
|
|
33.
|
Merrill RM, Henson DE and Barnes M:
Conditional survival among patients with carcinoma of the lung.
Chest. 116:697–703. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Maes H, Rubio N, Garg AD and Agostinis P:
Autophagy: shaping the tumor microenvironment and therapeutic
response. Trends Mol Med. 19:428–446. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Pujol JL, Quantin X, Jacot W, Boher JM,
Grenier J and Lamy PJ: Neuroendocrine and cytokeratin serum markers
as prognostic determinants of small cell lung cancer. Lung Cancer.
39:131–138. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Giovanella L, Piantanida R, Ceriani L, et
al: Immunoassay of neuron-specific enolase (NSE) and serum
fragments of cytokeratin 19 (CYFRA 21.1) as tumor markers in small
cell lung cancer: clinical evaluation and biological hypothesis.
Int J Biol Markers. 12:22–26. 1997.
|
